1Filly R, Bland N, Castellino RA. Radiographic diatribution of in- trathoracic disease in previously untreated patients with Hedgkins disease and non - Hodgkin B lymphoma. Radiology, 1976, 120 (2) :277 -281.
2叶任高,陆再英,主编.内科学.第6版.北京:人民卫生出版社,2005.869.
3Inoue R,Natazuka T,Shimoyama M. Feasibility of high-dose chemotherapy without stem cell support as a first-line treatment for non-Hodgkin's aggressive lymphoma:a pilot study[J].Leukemia and Lymphoma,2000,(3-4):315-321.
4Messori A,Vaiani M,Trippoli S. Survival in patientswith intermediate or high grade non-Hodgkin's lymphoma:meta-analysis of randomized studies comparing third generationregimens with CHOP[J].British Journal of Cancer,2001,(03):303-307.
5Multani P,White C A,Grillo-Lopez A. Non-Hodgkin's lymphoma:review of conventional Treatments[J].Curr pharmbiotechnol,2001,(04):279-291.
6Philip T,Guglielmi C,Hagenbeek A. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma[J].New England Journal of Medicine,1995,(23):1540-1545.
7Haim N,Rosenblatt E,Wollner M. Salvage therapy for non-Hodgkin's lymphoma with a combination of dexamethasone,etoposide,ifosfamide and cisplatin[J].Cancer Chemotherapy and Pharmacology,1992,(03):243-244.
8Coleman M,Leonard J,Shuster M W. DICE(dexamethasone,etoposide,ifosfamide and cisplatin)infusional chemotherapy for refractory or replased non-Hodgkin's lymphoma(NHL)[J].European Journal of Haematology Supplementum,2001,(01):41-45.
